486 related articles for article (PubMed ID: 27265844)
21. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
[TBL] [Abstract][Full Text] [Related]
22. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
23. Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes.
Gormsen LC; Søndergaard E; Christensen NL; Brøsen K; Jessen N; Nielsen S
Diabetologia; 2019 Jul; 62(7):1251-1256. PubMed ID: 30976851
[TBL] [Abstract][Full Text] [Related]
24. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial.
Hoyos CM; Yee BJ; Phillips CL; Machan EA; Grunstein RR; Liu PY
Eur J Endocrinol; 2012 Oct; 167(4):531-41. PubMed ID: 22848006
[TBL] [Abstract][Full Text] [Related]
25. Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
Andrology; 2017 Sep; 5(5):905-913. PubMed ID: 28771964
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial.
Snaith JR; Samocha-Bonet D; Evans J; Liu Z; Kowalski G; Bruce C; Holmes-Walker DJ; Greenfield JR
Diabet Med; 2021 Sep; 38(9):e14564. PubMed ID: 33774848
[TBL] [Abstract][Full Text] [Related]
27. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
[TBL] [Abstract][Full Text] [Related]
28. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
[TBL] [Abstract][Full Text] [Related]
29. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism.
Arslanian S; Suprasongsin C
J Clin Endocrinol Metab; 1997 Oct; 82(10):3213-20. PubMed ID: 9329341
[TBL] [Abstract][Full Text] [Related]
30. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
31. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes.
Rodríguez-Moctezuma JR; Robles-López G; López-Carmona JM; Gutiérrez-Rosas MJ
Diabetes Obes Metab; 2005 Mar; 7(2):189-92. PubMed ID: 15715892
[TBL] [Abstract][Full Text] [Related]
32. Hepcidin Reduction during Testosterone Therapy in Men with Type 2 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Study.
Magnussen LV; Helskov Jørgensen L; Glintborg D; Andersen MS
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137405
[TBL] [Abstract][Full Text] [Related]
33. Effect of metformin and insulin vs. placebo and insulin on whole body composition in overweight patients with type 2 diabetes: a randomized placebo-controlled trial.
Nordklint AK; Almdal TP; Vestergaard P; Lundby-Christensen L; Boesgaard TW; Breum L; Gade-Rasmussen B; Sneppen SB; Gluud C; Hemmingsen B; Perrild H; Madsbad S; Mathiesen ER; Tarnow L; Thorsteinsson B; Vestergaard H; Lund SS; Eiken P
Osteoporos Int; 2021 Sep; 32(9):1837-1848. PubMed ID: 33594488
[TBL] [Abstract][Full Text] [Related]
34. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
35. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
36. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
[TBL] [Abstract][Full Text] [Related]
38. Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial.
Feng WH; Bi Y; Li P; Yin TT; Gao CX; Shen SM; Gao LJ; Yang DH; Zhu DL
J Diabetes Investig; 2019 Mar; 10(2):399-407. PubMed ID: 29957886
[TBL] [Abstract][Full Text] [Related]
39. DHEA in elderly women and DHEA or testosterone in elderly men.
Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
[TBL] [Abstract][Full Text] [Related]
40. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
